A bipartisan congressional report estimates overdose deaths cost the United States $1 trillion yearly; 4 states announce plans to lift their statewide mask mandates for schools; study finds greater risk of pregnancy complications in expectant mothers with moderate COVID-19 symptoms.
A new bipartisan congressional report published today found that drug overdoses, primarily those stemming from synthetic opioids, have cost the United States approximately $1 trillion yearly. ABC News reports that drug overdose deaths have more than doubled in recent years, rising from 44,000 to 2013 to over 100,000 between May 2020 and April 2021. As opioid drugs, particularly fentanyl, continue to drive record overdose deaths, a bipartisan congressional commission advocated for a multipronged strategy and cabinet-level leadership to counter the worsening overdose epidemic.
NPR reports that 4 states, Oregon, New Jersey, Connecticut, and Delaware, have announced plans this week to lift their respective statewide mask mandates for schools. The loosening COVID-19 restrictions are set to take effect in Connecticut on February 28, the earliest of the 4 states, with Oregon and Delaware noted as the latest to set plans for March 31. The mask mandate in New Jersey will lift for both students and employees beginning March 7, with districts allowed to require masking thereafter to control any spikes in infections.
As reported by USA Today, a study funded by the National Institutes of Health highlighted the protective benefits of vaccines for expectant mothers and their babies, in utero and after birth. Including 13,000 expectant mothers in the analysis, of which 2400 were infected, findings indicated that pregnant women with moderate COVID-19 symptoms were at greater risk for pregnancy complications than those not infected or with mild to no symptoms. Complications included higher chances of requiring cesarean section, delivering preterm, and mortality around the time of birth.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Vaccine Hesitancy: COVID-19 to Influenza
October 22nd 2024Vaccine hesitancy grew more prominently in the wake of COVID-19 and the spread of misinformation. This flu season, seeking out reliable sources of health information will help individuals make the best decisions to protect themselves.
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
Cost Savings From an mHealth Tool for Improving Medication Adherence
October 21st 2024The Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.
Read More